Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-028056
Filing Date
2013-05-13
Accepted
2013-05-13 06:19:06
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v343468_10q.htm 10-Q 533925
2 EXHIBIT 31.1 v343468_ex31-1.htm EX-31.1 9653
3 EXHIBIT 31.2 v343468_ex31-2.htm EX-31.2 9312
4 EXHIBIT 32.1 v343468_ex32-1.htm EX-32.1 4988
5 EXHIBIT 99.1 v343468_ex99-1.htm EX-99.1 36351
12 GRAPHIC tlogo.jpg GRAPHIC 3027
  Complete submission text file 0001144204-13-028056.txt   3748337

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adhxf-20130331.xml EX-101.INS 364916
7 XBRL TAXONOMY EXTENSION SCHEMA adhxf-20130331.xsd EX-101.SCH 36979
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adhxf-20130331_cal.xml EX-101.CAL 30903
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adhxf-20130331_def.xml EX-101.DEF 163887
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adhxf-20130331_lab.xml EX-101.LAB 303391
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adhxf-20130331_pre.xml EX-101.PRE 188730
Mailing Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703
Business Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 919-484-8484
ADHEREX TECHNOLOGIES INC (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 13835285
SIC: 2836 Biological Products, (No Diagnostic Substances)